Sofia Cerdeira
Contact information
+44 (0)1865 221021
Colleges
Collaborators
Honours and Awards
- HIMSS FUTURE50-Europe Class 2019
- L'Oreal-Unesco For Women in Science Award - High Commendation - 2019
- UNIVANTS of Healthcare Excellence Award - 2019
- Canon Fellowship, Canon Foundation in Europe - 2019
- HSJ Healthcare Partnership Award - 2019
- Africa Oxford Initiative Travel Grant, University of Oxford - 2018
- NIHR Academic Clinical Lectureship - 2017
- Junior Research Fellowship, Somerville College, University of Oxford - 2015
- NIHR Academic Clinical Fellowship - 2014
- Vision Grant Award, Preeclampsia Foundation, USA - 2013
- Best Data Club presentation of the year award - CVBR - Harvard University - 2012
- Excellence in Tutoring Award - Physiology, Harvard Medical School - 2012
A. Sofia Cerdeira
MD PhD
NIHR Academic Clinical Lecturer
- Junior Research Fellow Somerville College Oxford
- Specialty Trainee in Obstetrics and Gyneacology Health Education Thames Valley
Research groups
L'Oreal-Unesco For Women in Science finalists
HSJ Healthcare Partnership Award
Key publications
-
Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia.
Journal article
Cerdeira AS. et al, (2019), Hypertension (Dallas, Tex. : 1979), HYPERTENSIONAHA11912739 - HYPERTENSIONAHA11912739
-
Taming preeclampsia at its source
Journal article
Cerdeira AS. and Vatish M., (2018), Nature Biotechnology, 36, 1151 - 1152
Recent publications
-
In vivo evidence of significant placental growth factor release by normal pregnancy placentas
Journal article
Cerdeira AS. et al, (2020), Scientific Reports, 10
-
Performance of sFlt-1/PlGF ratio ≥85 for ruling in preeclampsia within 4 weeks
Journal article
Sofia CERDEIRA A. et al, (2020), American Journal of Obstetrics and Gynecology
-
The value of MRI in management of uterine fibroids in pregnancy
Journal article
Cerdeira AS. et al, (2020), European Journal of Obstetrics & Gynecology and Reproductive Biology
-
One Step Closer to a Cure for Preeclampsia?: Boosting the Natural Affinity of VEGF (Vascular Endothelial Growth Factor) to sFlt (Soluble fms-Like Tyrosine Kinase)-1.
Journal article
Cerdeira AS. et al, (2020), Hypertension (Dallas, Tex. : 1979), 76, 1081 - 1083
research
Pre-eclampsia, angiogenic factors
I am a clinician scientist with a particular interest in pre-eclampsia and angiogenic factors. We recently conducted the first clinical trial on the use of sFlt-1/PlGF ratio in the management of patients with suspected pre-eclampsia (Cerdeira AS et al. Hypertension 2019). Data from our study and previous observations lead to the development of a protocol that is now used in clinical practice. My aim is to continue exploring the role of angiogenic factors in the prediction, diagnosis and treatment of pre-eclampsia, hopefully leading to meaningful changes in patient care.
news featuring:
https://www.thetimes.co.uk/article/new-blood-test-takes-doubt-out-of-pre-eclampsia-pp5mmv30p
https://www.ouh.nhs.uk/news/article.aspx?id=1058